BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 3543637)

  • 1. Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: implications for the pathogenesis of hyperparathyroidism in chronic renal failure.
    Parfitt AM; Kleerekoper M; Cruz C
    Miner Electrolyte Metab; 1986; 12(5-6):356-62. PubMed ID: 3543637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of effect of 24,25-dihydroxycholecalciferol on serum immunoreactive PTH in patients with persistent hyperparathyroidism after renal transplantation.
    Friedlander MA; Horst RL; Hawker CD
    Clin Nephrol; 1984 Oct; 22(4):206-10. PubMed ID: 6391769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normocalcemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium.
    Gardin JP; Paillard M
    Miner Electrolyte Metab; 1984; 10(5):301-8. PubMed ID: 6493158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent.
    Hirschel-Scholz S; Caverzasio J; Bonjour JP
    J Clin Invest; 1985 Nov; 76(5):1851-6. PubMed ID: 2997292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation between the effects of endogenous parathyroid hormone on adenosine 3',5'-monophosphate generation and phosphate reabsorption in hypocalcemia due to vitamin D depletion: an acquired disorder resembling pseudohypoparathyroidism type II.
    Rao DS; Parfitt AM; Kleerekoper M; Pumo BS; Frame B
    J Clin Endocrinol Metab; 1985 Aug; 61(2):285-90. PubMed ID: 2989317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial benign hypercalcaemia. Study of a large family.
    Menko FH; Bijvoet OL; Fronen JL; Sandler LM; Adami S; O'Riordan JL; Schopman W; Heynen G
    Q J Med; 1983; 52(206):120-40. PubMed ID: 6310672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
    Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
    Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis.
    Ambühl PM; Meier D; Wolf B; Dydak U; Boesiger P; Binswanger U
    Am J Kidney Dis; 1999 Nov; 34(5):875-83. PubMed ID: 10561144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Handling of phosphate by the transplanted kidney.
    Graf H; Kovarik J; Stummvoll HK; Wolf A; Pinggera WF
    Proc Eur Dial Transplant Assoc; 1979; 16():624-9. PubMed ID: 398523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proximal tubular defects in idiopathic hypercalciuria: resistance to phosphate administration.
    Lau YK; Wasserstein A; Westby GR; Bosanac P; Grabie M; Mitnick P; Slatopolsky E; Goldfarb S; Agus ZS
    Miner Electrolyte Metab; 1982; 7(5):237-49. PubMed ID: 7169988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
    Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
    Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphate metabolism in renal stone formers. (II): Relation to renal tubular functions and calcium metabolism.
    Wikström B; Backman U; Danielson BG; Fellström B; Johansson G; Ljunghall S; Wide L
    Scand J Urol Nephrol Suppl; 1981; 61():II:1-26. PubMed ID: 6274002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic studies in a patient with idiopathic hypophosphatemic osteomalacia.
    Weiss M; Schechter P; Bab I; Mekhmandarov S; Bank H; Eisenstein Z
    Isr J Med Sci; 1988 Jan; 24(1):46-50. PubMed ID: 3346150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenous cyclic adenosine monophosphate levels in normocalcemic cancer patients: its significance.
    Abramson EC; Kukreja SC; Lad TE; Shemerdiak WP; York PA
    Horm Metab Res; 1984 Apr; 16(4):204-7. PubMed ID: 6327481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reelevation of parathyroid hormone level after parathyroidectomy in patients with primary hyperparathyroidism: importance of decreased renal parathyroid hormone sensitivity.
    Yamashita H; Noguchi S; Moriyama T; Takamatsu Y; Sadanaga K; Uchino S; Watanabe S; Ogawa T
    Surgery; 2005 Apr; 137(4):419-25. PubMed ID: 15800489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo studies of parathyroid gland function in secondary hyperparathyroidism.
    Salusky IB; Goodman WG
    Adv Nephrol Necker Hosp; 1996; 25():289-302. PubMed ID: 8717632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute oral calcium load decreases parathyroid secretion and suppresses tubular phosphate loss in long-term renal transplant recipients.
    Dumoulin G; Hory B; Nguyen NU; Henriet MT; Bresson C; Regnard J; Saint-Hillier Y
    Am J Nephrol; 1995; 15(3):238-44. PubMed ID: 7618649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the pre-transplant bone-mineral metabolism do not affect the initial progress of the renal graft].
    Rodrigo Calabia E; Ruiz San Millán JC; Gago M; Ruiz Criado J; Piñera Haces C; Fernández Fresnedo G; Palomar R; Gómez Alamillo C; Martín de Francisco AL; Arias M
    Nefrologia; 2009; 29(2):143-9. PubMed ID: 19396320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.